EIT Health Germany’s Expert Panel
Jury & Reviewer Pool

  • Daniela Amann, Geschäftsbereichsleiterin Kundenbindung & Versorgung, Die Schwenninger Krankenkasse
  • Dr. med. Rolf Baß, Adjunct Professor for Pharmaceutical and Toxicology, Charité, Universitätsmedizin Berlin
  • Dr. Siegfried Bialojan, Executive Director, Ernst & Young GmbH, Head Life Science Center
  • Dr. Elmar Bourdon, Manager, Mannheim Medical Technology Cluster, Office of Economic Development, City of Mannheim
  • Prof. Horst Domdey, Managing Director, BioM Biotech Cluster Development GmbH
  • Dr. Gerald Drewes, Head of Science, Cellzome GSK
  • Dr. Peter Haug, Head of Business Development & Licensing, Oncgnostics GmbH
  • Dr. Peter Johann, Managing General Partner, NGN Capital LLC
  • Dr. Bernhard Kirschbaum, Protagen Diagnostics & Omeicos Therapeutics
  • Dr. Oliver Ladendorf, Patentanwalt & European Patent Attorney, Kraus & Weisert
  • Dr. Peter Müller, CEO, Stiftung Gesundheit
  • Prof. Dr. med. Dr. rer. pol. Konrad Obermann, Senior Lecturer at the MIPH (Mannheim Institute of Public Health), University of Heidelberg & Consultant in international health economics, health care financing and social protection
  • Dr. Patrick Pfeffer, CEO, aescuvest
  • Dr. Andreas Rauh, Managing Partner, Management Institut für den Mittelstand
  • Dr. Philipp Rittershaus, Investment Manager, High-Tech Gründerfonds
  • Kurt Schlegel, Wirtschaftssenior, Aktivitäten u.a. Industrie 4.0 / IT Sicherheit
  • Prof. Dr. Freimut Schliess, Director Science & Innovation, Profil Insitut für Stoffwechselforschung GmbH
  • Dr. Stefan Simianer, General Manager, Research & Development, AbbVie Deutschland GmbH & Co. KG
  • Dr. Matthias Stein-Gerlach, Patent & Licensing Manager, Max-Planck Innovation GmbH
Back to top
Image of

Close